INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic...

25

Transcript of INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic...

Page 1: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines
Page 2: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

INVESTORPRESENTATION

Q4 2019-20

Page 3: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Disclaimer

This information may contain certain forward-looking statements/details in the currentscenario, which is extremely dynamic and increasingly fraught with risks and uncertainties.Actual results, performances, achievements or sequence of events may be materiallydifferent from the views expressed herein. Investors/shareholders/public are hencecautioned not to place undue reliance on these statements/details, and are advised toconduct their own investigation and analysis of the information contained or referred to inthis section before taking any action with regard to their own specific objectives. None ofthe companies described herein or any of their respective affiliates, advisors orrepresentatives shall have any liability whatsoever (in negligence or otherwise) for anyloss howsoever arising from any use of the Materials or their contents or otherwise arisingin connection with the Materials. Further, the discussion following herein reflects theperceptions on major issues as on date and the opinions expressed herein are subject tochange without notice. The Company undertakes no obligation to publicly update orrevise any of the information, opinions or forward-looking statements expressed in thissection, consequent to new information, future events or otherwise.

Page 4: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Presentation Outline

Sr. No. Particulars

1. Torrent Group 2. Torrent Power Limited3. Overview of Operations : FY 2019-204. Investment Rationale 5. Five Year Trend : Key Financial & Technical Statistics

Page 5: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

1. Torrent Group

Torrent

TORRENT PHARMACEUTICALS LIMITED• A generics pharmaceutical major with strong global footprint• Ranked in top 10 in Indian pharma market with leading position in niche

therapeutic areas• Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

TORRENT POWER LIMITED• Leading private sector Integrated Power Utility with presence across

generation, transmission and distribution• Lowest distribution losses in the country• 24 X 7 power supply in licensed areas• Excellent operational track record with delightful customer service

TORRENT GAS PRIVATE LIMITED• New business vertical for City Gas Distribution business• 13 CGD areas won in the 9th & 10th Round of Bidding by PNGRB• 3 CGD areas acquired from incumbent players• Capex plan of ~ Rs. 8,700 crs over next 5 years.

Page 6: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Torrent Group (Contd…)

Not just healthcare… Lifecare

Turnover: $ 1109 MnEnterprise Value: $ 5193 MnMarket Cap: $ 4426 MnEmployees: 13800+

Generating Trust. Distributing Opportunities.

Building pan-India state-of-art city gas distribution networks in 16 GAs across 7 StatesEmployees: 450+

Spreading smiles Illuminating Lives

Turnover $ 2918 Mn

Enterprise Value $ 8152 Mn

Market Cap $ 6204 Mn

Employees 22,100+

Turnover: $ 1809 Mn

Enterprise Value: $ 2959 Mn

Market Cap: $ 1778 Mn

Employees: 7850+

Page 7: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

2. Torrent Power Limited

Spreading smiles Illuminating Lives

- 2730 MW of gas

based plants

- 362 MW of coal

based plant

- 138 MW of

operational

portfolio

- 430 MW ofoperationalportfolio

- 975 MW underpipeline

- 355 km 400 kV

double circuit

lines to evacuate

power from gas

based plants

- Licenseddistributionareas coveringAhmedabad /Gandhinagar,Surat, & DahejSEZ

- Franchiseddistributionareas coveringBhiwandi & Agra

Thermal Solar Wind Transmission Distribution

-2730 MW state-of-art gas basedpower plants

-362 MW of coalbased plant

-138 MW oper-ational capacityover 2 locations

-649 MW oper-ational capacityover 7 locations

-355 kms 400 kV& 128 Kms of220 KV, doublecircuit lines toevacuate powerfrom gas basedplants

- Licenseddistribution areascovering Ahmed-abad / Gandhi-nagar, Surat,Dahej SEZ &Dholera SIR

-Franchiseddistribution areascoveringBhiwandi, Agra &SMK

ASSETS AT A GLANCE

Page 8: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Torrent Power Limited (Contd…)

PORTFOLIO OF ASSETS : THERMAL GENERATION

1147.5 MW(3 x 382.5)

382.5 MW(1 x 382.5)

1200 MW(3 x 400)

362 MW(1 x 120 MW, 2 x 121 MW)

Gas-based CCPP Gas-based CCPP Gas-based CCPP Coal Based

Near Surat, Gujarat Near Surat, Gujarat Near Bharuch, Gujarat Ahmedabad, Gujarat

August - 2009 April - 2013 December - 2014 1988

Domestic gas & Imported LNG Imported LNG Imported LNG

Domestic & Imported Coal

835 MW for Distribution areas of Ahmedabad /

Gandhinagar & Surat, and 75 MW with MP

278 MW for Distribution areas of Ahmedabad / Gandhinagar & Surat

No tie up

Embedded generation for licensed areas of

Ahmedabad / Gandhinagar

Contracted Storage-cum-Regasification capacity of 1 MTPA with Petronet LNG, Dahej Terminal for 20 years from April 2017

Page 9: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Torrent Power Limited (Contd…)

PORTFOLIO OF ASSETS : RENEWABLE GENERATION

51 87 49.6 201.6 50.9 50.4 120 126 50

Patan in Gujarat

Adjacent to SUGEN

Plant, Gujarat

Jamnagar in Gujarat

Kutch in Gujarat

Rajkot in Gujarat

Bhavnagar in Gujarat

Gulbarga & Raichur in Karnataka

OsmanabadMaharashtra

Kutch, Gujarat

FY 15 FY 16 FY 12 FY 17 FY 19 FY 19 FY 18 FY 20 FY 20

10.03 6.74 4.15 4.19 4.19 4.19 3.74 2.87 3.46

FiT with Company’s Licensed Distribution business FiT with GESCOM, Karnataka

MSEDCL (TBCB)

PTC (TBCB thru SECI)

18.54% 16.32% 21.83% 31.47% 27.85% 28.62% 34.17% 21.18%* 9.64%** Commissioned during the year

Page 10: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Torrent Power Limited (Contd…)

PORTFOLIO OF ASSETS : DISTRIBUTION

ParticularsLicensed Distribution Franchised Distribution

Ahmedabad/Gandhinagar

Surat Dahej Bhiwandi Agra

Licensed Area

~ 356 sq. km. ~ 52 sq.

km. ~ 17 sq. km. ~ 721 sq. km. ~ 221 sq. km.

Peak Demand

2,018 MW 695 MW 72 MW 580 MVA 473 MVA

License validity

Till 2025 Till 2028 Till 2034 25th Jan 2027 31st March 2030

Accolades

T&D loss 4.53% during FY 20, is amongst the lowest in the country

Substantial distribution network undergrounded

Consumers enjoy enviable power availability of 99.9%, which is among the highest in the country.

Second Licensee at Dahej SEZMinimal Distribution losses~ 100% power reliability

Country's first unique PPP distribution franchisee agreement with MSEDCL, now adopted as a standard model for distribution reforms in the country

Reduction in AT&C losses from 58% at the time of takeover to 11.93% in FY 20.

Reliable power supply & improved customer services

Reduction in AT&C losses from 58.77% at the time of takeover to 12.51% in FY 20.

Reliable power supply & improved customer services

Page 11: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

The Company has been awarded distribution license for Dholera Special Industrial Region(Dholera SIR) of ~920 Sq Kms for 25 years as additional licensee

Dholera SIR is a major project in the Delhi-Mumbai Industrial Corridor (DMIC), to bedeveloped into a global manufacturing hub supported by world class infrastructure

~Rs 500 Crs of capex is estimated in the licensed area over 5 years, depending on how industries come up in the area

Cost plus ROE business model, ensuring atleast post-tax ROE of 14%

A new state-of-art network & a large industrial base will ensure minimal T&D losses & low cost of supply.

Network development work is under progress; Aggregate capex incurred till date ~ Rs 67 crs;

Torrent Power Limited (Contd…)

PORTFOLIO OF ASSETS : UPCOMING DISTRIBUTION LICENSE AREA

Page 12: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

TPL has been awarded the distribution franchise for Shil, Mumbra & Kalwa area byMSEDCL, based on competitive bidding process for 20 years.

The operations have been taken over w.e.f. March 01, 2020.

The ~65 Sq Kms area is part of Thane Urban Circle of MSEDCL and is emerging as one ofthe fast growing satellite urban centre of Mumbai with promising growth prospects.

Bid Levelised input power purchase Rs. 4.87/kWh (Benchmark Levelised input powerpurchase Rs. 4.82 / kWh)

~Rs 300 Crs of capex is estimated in the franchised area over the term, of which ~Rs 150Crs of capex is estimated to be invested in first 5years.

Reported AT&C loss for base year 2016-17 is 47% March 20 AT&C ~ 75% (includes COVID-19 impact) Expected reduction by 15th year – 12%

P&L accretive in 5 years

Torrent Power Limited (Contd…)PORTFOLIO OF ASSETS : UPCOMING DISTRIBUTION FRANCHISE AREA

Page 13: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

3. Overview of Operations – FY 2019-20

Particulars (Rs. Cr.)Q4 19-20 Audited

Q4 18-19 Audited

Growth %

FY 19-20Audited

FY 18-19Audited

Growth %

Revenue from Operations 2,984 2,925 2% 13,641 13,151 4%Power Purchase Cost 1,584 1,717 7,960 8,136Material Cost & Change in Inventory 54 121 306 470

Contribution 1,346 1,087 24% 5,375 4,545 18%Other Income 37 40 178 190Gen. & Admin Exp. 519 377 1,819 1,346PBDIT 864 750 15% 3,734 3,389 10%Finance Cost 222 216 955 899Depreciation & amortization 335 313 1,304 1,227

OCI / (Exp.) (25) (11) (45) (10)Profit Before Exceptional Items and Tax

282 210 34% 1,430 1,254 14%

Exceptional Items (1,000) - (1,000) -Profit Before Tax (718) 210 (442%) 430 1,254 (66%)Tax Expenses (428) 192 (720) 356TCI (290) 18 (1709%) 1,150 898 28%

CONSOLIDATED INCOME STATEMENT

Page 14: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Overview of Operations – FY 2019-20 (Contd…)

Increase in contribution from gas-based power plants, due to operationalization of long term PPA for 278MWs capacity from Q2 19-20 & higher merchant power sales after offsetting loss in contribution due toreduction in tariffs in new CERC Tariff Regulations;

Improved performance of licensed & franchised distribution businesses, primarily driven by volume growth(net of COVID-19 impact), reduction in T&D losses and favourable settlement of past regulatory disputeon carrying cost, partially set off by initial costs on takeover of Shil-Mumbra-Kalwa operations andadditional provision for doubtful debts in its franchised distribution business due to COVID 19 impact;

Increase in contribution from Renewable generation due to new capacity addition; Recognition of net deferred tax credit mainly due to reduction in MAT rate vide Taxation Laws

(Amendment) Act, 2019, provision for impairment in the carrying value of DGEN Power Plant, provisionfor certain onerous contracts and reassessment of management’s reasonable estimate for the futuretaxable profits, which would be available to utilize such accumulated MAT Credit in future years;

The TCI includes non-recurring charges on account of, (a) provision for impairment loss (non-cash bookadjustment under applicable accounting standard) on carrying value of Property, Plant & Equipmentpertaining to 1,200 MW DGEN Mega Power Project; and (b) provision towards potential damages andother project related costs arising from expected delays or cancellation of 2 wind power projects wonunder competitive bidding process in an earlier year due to reasons beyond the control of the Company;

Increase in depreciation and interest cost, reflecting additional capex in distribution and renewableprojects.

The major drivers of increase in the reported Total Comprehensive Income for the year are:

Dividend:The Company had announced an Interim dividend (including Special divided) for FY 2019-20 of ₹ 11.60 per equity share (including ₹ 5.00 as special dividend), which was paid in February 2020. The Board has not considered any further dividends for FY 2019-20.

Page 15: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Overview of Operations – FY 2019-20 (Contd…)

SUGEN1147.5 MW

UNOSUGEN382.5 MW

DGEN1200 MW

AMGEN362 MW

THERMAL3092 MW

54.3%

0.0% 0.0%

87.2%

30.4%41.6%

68.2%

7.7%

51.8%32.9%

Q4 Thermal PLF (%)/ Net Generation (MUs)

Q4 2018-19 Q4 2019-20

1312MUs 1013

MUs

624MUs

370MUs

197MUs

1936MUs

2134MUs

554MUs

SUGEN1147.5 MW

UNOSUGEN382.5 MW

DGEN1200 MW

AMGEN362 MW

THERMAL3092 MW

62.3%

0.0% 0%

87.8%

33.4%

59.9% 60.1%

6.5%

72.9%

40.7%

FY Thermal PLF (%)/ Net Generation (MUs)

FY 2018-19 FY 2019-20

6105MUs 5870

MUs

2550MUs

2112MUs

668MUs

8655MUs

10615MUs

1964MUs

Page 16: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Overview of Operations – FY 2019-20 (Contd…)

264MUs

WIND SOLAR

22.17%20.25%

23.62%

19.30%

Q4 Renewable PLF (%)/MUs Dispatched

Q4 2018-19 Q4 2019-20

60MUs

58MUs

217MUs

345MUs

473 MW 599 MW 138 MWWIND SOLAR

30.08%

17.57%

29.76%

17.14%

Q4 Renewable PLF (%)/MUs Dispatched

FY 2018-19 FY 2019-20

212MUs

208MUs

473 MW 599 MW 138 MW

1137MUs

1330MUs

Page 17: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Overview of Operations – FY 2019-20 (Contd…)

A'bad Surat Bhiwandi Agra

1,658

773 911 351

1,541

739 878

343

Q4 USO/Purchase (MUs)

Q4 18-19 Q4 19-20

A'bad Surat Bhiwandi Agra

8,301 3,392 3,622

2,017

8,232 3,403 3,682

2,059

FY USO/Purchase (MUs)

FY 18-19 FY 19-20

Page 18: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

4. Investment Rationale

• State of the art gas based plants

• Direct import of LNG at efficient cost

• Low environmental footprint & large quantum of renew-ables in power system creates a favourable conditions for sustain-able operations of unutilised capacities

• Govt contemplating scheme for revival of gas based plants –expected to benefit Dgen

Thermal Generation

• Huge growth potential in renew-ables; expect the returns to rise above COE as bidding intensity moderates

• Company’s right to win : strong project development, O&M & financial capabilities

• Opportunity of flexible generation to sell pooled RTC power [Renewable + Gas] at competitive cost on a long term basis

Renewable Generation

• Need for a robust grid to support huge increase in renewables capacity presents attractive opportunities for private transmission players

• Robust regulations & limited project risks

• Company’s right to win : strong project development & financial capabilities

Transmission

• Opportunities for private sector considering the endemic inefficiencies of the public distribution sector

• Torrent has a strong distribution platform to take advantage of upcoming Franchisee & privatisation opportunities in distribution sector

Distribution

Page 19: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Investment Rationale (Contd…)

Value Creation

World class generation

assets

Unmatched distribution

model

Regulated businesses ensuring

stable returns

Excellent operational

records Promising growth

opportunities

Strong project management

skills

Rational allocation of

capital

Page 20: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

5. Five Year Trend - Key Financial Statistics

2015-16 2016-17 2017-18 2018-19 2019-20

1171610000

1151213151 13641

Revenues from Operations (₹ Crore)

2015-16 2016-17 2017-18 2018-19 2019-20

3336

2651

3381 33893734

EBIDTA (₹ Crore)/EBIDTA Margin (%)

2015-16 2016-17 2017-18 2018-19 2019-20

893

423

956 893

1145

TCI (₹ Crore)

2015-16 2016-17 2017-18 2018-19 2019-20

7807 82579235

105699722

Net Worth (₹ Crore)

28%27%

29%

26%27%

Note: FY 2015-16 onwards Financials are based on IND AS. From 1st April 2018, the Company has adopted Ind AS 115, Revenue from Contracts with Customers , hence the numbers of previous periods are not comparable. Net worth includes DTL.

Page 21: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Five Year Trend - Key Financial Statistics (Contd…)

Note: FY 2015-16 onwards Financials are based on IND AS. From 1st April 2018, the Company has adopted Ind AS 115, Revenue from Contracts with Customers , hence the numbers in previous periods are not comparable.

0.93 0.920.89

0.80 0.80

2015-16 2016-17 2017-18 2018-19 2019-20

Net Debt Equity Ratio

11.21%

7.31%

9.62%

8.23%9.32%

2015-16 2016-17 2017-18 2018-19 2019-20

Return on Capital Employed

2.26

2.992.49 2.61

2.18

2015-16 2016-17 2017-18 2018-19 2019-20

Net Debt / EBITDA

13.22%

5.57%

12.62%

9.54%11.05%

2015-16 2016-17 2017-18 2018-19 2019-20

Return on Networth

Page 22: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Five Year Trend - Key Technical Statistics (Contd…)

95.63% 95.10% 94.17% 93.14% 92.77%

65.05%74.64% 71.38%

87.80%72.90%

2015-16 2016-17 2017-18 2018-19 2019-20

AMGEN PAF-PLF (%)

PAF PLF

98.38% 96.38% 95.86% 98.46% 96.75%

35.78%47.50%

65.26% 62.29% 59.89%

2015-16 2016-17 2017-18 2018-19 2019-20

SUGEN PAF-PLF (%)

PAF PLF

22.35% 21.69% 17.58% 15.13% 11.93%

29.25%24.69% 19.16%

14.18% 12.51%

2015-16 2016-17 2017-18 2018-19 2019-20

T&D loss (%)Distribution Franchisee

Bhiwandi Agra

7.15% 6.81% 6.31%5.61%

4.98%3.89% 3.92% 3.59% 3.43% 3.43%

0.76% 0.53% 0.40% 0.35% 0.31%

2015-16 2016-17 2017-18 2018-19 2019-20

T&D loss (%)Distribution Licensee

A'bad Surat Dahej

Note: PLF % in Amgen till FY 17-18 is including C Station which has been retired w.e.f. 02nd April 2018.

Page 23: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

THANK YOU

www.torrentpower.com

Contact details: Rishi Shah

Torrent Power Limited “Samanvay”, 600 Tapovan, Ambawadi,

Ahmedabad 380015 Ph. No. (079) 26628473

Email: [email protected]

Page 24: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Registered Office: “Samanvay”, 600, Tapovan, Ambawadi, Ahmedabad 380 015Phone: (079) 26628000, CIN: L31200GJ2004PLC044068

Website: www.torrentpower.com; E-mail: [email protected]

MEDIA RELEASE

In case of any enquiry / clarification, please contact Mr. Jayesh Desai on +91 9824501396

Revenue from Opera�ons₹ 2,984 crs in Q4 FY 2019-20 compared to ₹ 2,925 crs in Q4 FY 2018-19₹ 13,641 crs in FY 2019-20 compared to ₹ 13,151 crs in FY 2018-19

EBITDA₹ 864 crs in Q4 FY 2019-20 compared to ₹ 750 crs in Q4 FY 2018-19, up 15%₹ 3,734 crs in FY 2019-20 compared to ₹ 3,389 crs in FY 2018-19, up 10%

Total Comprehensive Income₹ (290) crs in Q4 FY 2019-20 compared to ₹ 18 crs in Q4 FY 2018-19 ₹ 1,150 crs in FY 2019-20 compared to ₹ 898 crs in FY 2018-19, up 28%

May 18, 2020: Torrent Power Limited (the “Company”) today announced financial results for the quarter and year ended March 31, 2020.

The major drivers of increase in the reported Total Comprehensive Income (TCI) for the year are:

ñ Increase in contribu�on from gas-based power plants, due to opera�onalisa�on of long term PPA for 278 MWs capacity from Q2 19-20 & higher merchant power sales a�er offse�ng loss in contribu�on due to reduc�on in tariffs in new CERC Tariff Regula�ons;

ñ Improved performance of licensed & franchised distribu�on businesses, primarily driven by volume growth (net of COVID-19 impact), reduc�on in T&D losses and favourable se�lement of past regulatory dispute on carrying cost, par�ally set off by ini�al costs on takeover of Shil-Mumbra-Kalwa opera�ons and addi�onal provision for doub�ul debts in its franchised distribu�on business due to COVID 19 impact;

ñ Increase in contribu�on from Renewable genera�on due to new capacity addi�on;ñ Recogni�on of net deferred tax credit mainly due to reduc�on in MAT rate vide Taxa�on Laws (Amendment) Act,

2019, provision for impairment in the carrying value of DGEN Power Plant, provision for certain onerous contracts and reassessment of management's reasonable es�mate for the future taxable profits, which would be available to u�lize such accumulated MAT Credit in future years;

ò The TCI includes non-recurring charges on account of, (a) provision for impairment loss (non-cash book adjustment under applicable accoun�ng standard) on carrying value of Property, Plant & Equipment pertaining to 1,200 MW DGEN Mega Power Project; and (b) provision towards poten�al damages and other project related costs arising from expected delays or cancella�on of 2 wind power projects won under compe��ve bidding process in an earlier year due to reasons beyond the control of the Company;

ò Increase in deprecia�on and interest cost, reflec�ng addi�onal capex in distribu�on and renewable projects.

Despite the above one-off impairment charge and provisions, the Total Comprehensive Income during FY 2019-20 increased by 28% to ₹ 1,150 crs from ₹ 898 crs in FY 2018-19.

The Company's financial posi�on strengthened during the year and the Company enjoys some of the best financial ra�os amongst private players in the Power sector with Debt : Equity ra�o of 0.92 as at March 31, 2020 and Net Debt to EBITDA ra�o of 2.18 during FY 2019-20.

TORRENT POWER REPORTS Q4 FY 2019-20 RESULTS

MajorHighlights

P1/2

Page 25: INVESTOR...• Ranked in top 10 in Indian pharma market with leading position in niche therapeutic areas • Ranked No. 1 among Indian Pharma companies in Brazil, Germany & Philippines

Registered Office: “Samanvay”, 600, Tapovan, Ambawadi, Ahmedabad 380 015Phone: (079) 26628000, CIN: L31200GJ2004PLC044068

Website: www.torrentpower.com; E-mail: [email protected]

MEDIA RELEASE

In case of any enquiry / clarification, please contact Mr. Jayesh Desai on +91 9824501396

The Company further cemented its leadership posi�on in the Power Distribu�on business during FY 20 with the takeover of distribu�on opera�ons of Shil-Mumbra-Kalwa area in Maharashtra under a distribu�on franchise agreement for 20 years wef March 01, 2020. The Company also increased its genera�on capacity from 3,703 MW to 3,879 MW during the year, with the en�re addi�on in capacity coming from Renewable energy.

Commen�ng on the results, the Company's Chairman, Mr Samir Mehta said “Despite the significant stress in the Power sector, Torrent Power con�nued to deliver industry leading returns in the private sector on account of the Company's strategy to pursue risk-adjusted profitable opportuni�es, strong execu�on capabili�es and focus on opera�onal excellence. We welcome the Government's recent announcements for the Power sector; in par�cular the decision to priva�se distribu�on circles in Union territories. With our strong balance sheet, the Company will con�nue to pursue profitable growth opportuni�es across the en�re value chain of the Power sector.”

The Company had announced an Interim dividend (including Special divided) for FY 2019-20 of ₹ 11.60 per equity share (including ₹ 5.00 per equity share as a special dividend), which was paid in February 2020. In view of the same, the Board has not considered any further dividends for FY 2019-20.

About Torrent Power:Torrent Power Limited, the ₹ 13,641 Crs integrated power u�lity of the ₹ 22,000 Crs Torrent Group, is one of the largest companies in the country's power sector with presence across the en�re power value chain – genera�on, transmission and distribu�on.

Genera�on:v The Company has an aggregate installed genera�on capacity of 3,879 MW comprising of 2,730 MW of gas-based

capacity, 362 MW of coal-based capacity and 787 MW of renewable capacity.

Distribu�on:v The Company distributes nearly 16.66 billion units to over 3.65 million customers in the ci�es of Ahmedabad,

Gandhinagar, Surat, Dahej SEZ and Dholera SIR in Gujarat, Bhiwandi, Shil, Mumbra and Kalwa in Maharashtra and Agra in U�ar Pradesh.

v Torrent Power is widely considered to be the leading power distributor in India and in its licensed areas in Gujarat has the dis�nc�on of having the lowest AT&C losses and best reliability indices.

TORRENT POWER REPORTS Q4 FY 2019-20 RESULTS

P2/2